Announced
Completed
MITOBRIDGE INC / ASTELLAS PHARMA INC. / Acquisition / Private / £335m
Synopsis
Tokyo, Japan-based Astellas Pharma Inc. acquired its partner Mitobridge, Inc., a biotechnology company focuses on mitochondrial therapeutics, for up to $450 million.
Principals
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.